ENDRA LIFE SCIENCES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2894 USD | -0.36% |
|
-4.36% | -86.34% |
| May. 14 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.21M | - | - | - | - | - | |
| 49.46B | - | |||||
| 42.58B | ||||||
| 42.49B | ||||||
| 29.09B | ||||||
| 26.61B |
